According to Aaron Pearson, he is Vice President of Public Relations at Stratasys 3D Printing, “The need for widespread COVID-19 testing of millions of people has surfaced another shortage, nasal swabs. Stratasys has added to its efforts to fight the pandemic and ongoing testing requirements by marketing and promoting Origin 3D-printed nasopharyngeal (NP) swabs to healthcare providers and other testing centers in the U.S. The Origin 3D-printed nasopharyngeal swab has been tested in a clinical trial and is considered an FDA Class I Exempt Device.”
This entry was posted in 3D /4D Printing Medical Technology/Dental/Orthopedics/ Pharmaceuticals/ Implants/ Invisiline/Dentures/ Virtual Reality., 3D Printing /4D Printing Services/ Industry News/ Business., 3D Printing 4D Printing's Network of Research/ Artificial Intelligence., 3D Printing Construction Technology/ Real Estate/ Housing/Architecture/ Challenges., 3D Printing/4D Printing /Biotechnology/Robotics., 3D/4D Printing//Customized Sports/Athlete Safety,, 3D/4D/5D Printing emergence., Policy. and tagged Aaron Pearson, FDA, nasal swabs, Nasal swabs and COVID-19 testing: the next step in the Stratasys pandemic response., Stratasys 3D Printing, Stratasys is helping nasal swabs and COVID-19 testing.